Multi-Faceted Analysis of COVID-19 Epidemic in Korea Considering Omicron Variant: Mathematical Modeling-Based Study

다국어 초록 (Multilingual Abstract)

Background: The most recent variant of concern, omicron (B.1.1.529), has caused numerous cases worldwide including the Republic of Korea due to its fast transmission and reduced vaccine effectiveness.
Methods: A mathematical model considering age-structure, vaccine, antiviral drugs, and influx of the omicron variant was developed. We estimated transmission rates among age groups using maximum likelihood estimation for the age-structured model. The impact of non-pharmaceutical interventions (NPIs; in community and border), quantified by a parameter μ in the force of infection, and vaccination were examined through a multi-faceted analysis. A theory-based endemic equilibrium study was performed to find the manageable number of cases according to omicron- and healthcare-related factors.
Results: By fitting the model to the available data, the estimated values of μ ranged from 0.31 to 0.73, representing the intensity of NPIs such as social distancing level. If μ < 0.55 and 300,000 booster shots were administered daily from February 3, 2022, the number of severe cases was forecasted to exceed the severe bed capacity. Moreover, the number of daily cases is reduced as the timing of screening measures is delayed. If screening measure was intensified as early as November 24, 2021 and the number of overseas entrant cases was contained to 1 case per 10 days, simulations showed that the daily incidence by February 3, 2022 could have been reduced by 87%. Furthermore, we found that the incidence number in mid-December 2021 exceeded the theory-driven manageable number of daily cases.
Conclusion: NPIs, vaccination, and antiviral drugs influence the spread of omicron and number of severe cases in the Republic of Korea. Intensive and early screening measures during the emergence of a new variant is key in controlling the epidemic size. Using the endemic equilibrium of the model, a formula for the manageable daily cases depending on the severity rate and average length of hospital stay was derived so that the number of severe cases does not surpass the severe bed capacity.

참고문헌 (Reference)

1 Gruell H, "mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant" 28 (28): 477-480, 2022

2 Cucinotta D, "WHO declares COVID-19 a pandemic" 91 (91): 157-160, 2020

3 Zhou R, "Vaccine-breakthrough infection by the SARSCoV-2 Omicron variant elicits broadly cross-reactive immune responses" 12 (12): e720-, 2022

4 Moore S, "Vaccination and non-pharmaceutical interventions for COVID-19 : a mathematical modelling study" 21 (21): 793-802, 2021

5 Eikenberry SE, "To mask or not to mask : modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic" 5 : 293-308, 2020

6 Kim S, "The impact of social distancing and public behavior changes on COVID-19transmission dynamics in the Republic of Korea" 15 (15): e0238684-, 2020

7 Seoul Metropolitan Government, "The Daily News Review of COVID-19(March 4, 2022)"

8 Kwon Seok Ryun ; Kim Namhee ; Park Hyunwoong ; Minn Dohsik ; Park Seungman ; Roh Eun Youn ; Yoon Jong Hyun ; Shin Sue, "Strong SARS-CoV-2 Antibody Response After Booster Dose of BNT162b2 mRNA Vaccines in Uninfected Healthcare Workers" 대한의학회 37 (37): 1-6, 2022

9 Christensen PA, "Signals of significantly increased vaccine breakthrough, decreased hospitalization rates, and less severe disease in patients with coronavirus disease 2019 caused by the Omicron variant of severe acute respiratory syndrome coronavirus 2 in Houston, Texas" 192 (192): 642-652, 2022

10 Lai CC, "Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges" 55 (55): 105924-, 2020

11 김소영 ; 김예진 ; Kyong Ran Peck ; 정은옥, "School Opening Delay Effect on Transmission Dynamics of Coronavirus Disease 2019 in Korea: Based on Mathematical Modeling and Simulation Study" 대한의학회 35 (35): 1-9, 2020

12 Rössler A, "SARS-CoV-2 Omicron variant neutralization in serum from vaccinated and convalescent persons" 386 (386): 698-700, 2022

13 Yi Seonju ; Kim Jong Mu ; 최영준 ; Hong Sujin ; Choi Siwon ; Ahn Seong Bae ; Kim Miya ; Park Young-Joon, "SARS-CoV-2 Delta Variant Breakthrough Infection and Onward Secondary Transmission in Household" 대한의학회 37 (37): 1-8, 2022

14 Korea Disease Control and Prevention Agency, "Regular Briefing(February 3, 2022)"

15 Korea Disease Control and Prevention Agency, "Regular Briefing(February 14, 2022)"

16 Korea Disease Control and Prevention Agency, "Regular Briefing (March 14, 2022)"

17 Roosa K, "Real-time forecasts of the COVID-19epidemic in China from February 5th to February 24th, 2020" 5 : 256-263, 2020

18 Korea Disease Control and Prevention Agency, "Public Health Weekly Report, PHWR (Vol.14, No.37, 2021)"

19 Hall V, "Protection against SARS-CoV-2 after COVID-19vaccination and previous infection" 386 (386): 1207-1220, 2022

20 Ministry of Health and Welfare, "Press release: introduction of 210,000 oral treatment for COVID-19, available from January 14 at the earliest"

21 김소영 ; 서유빈 ; 정은옥, "Prediction of COVID-19 transmission dynamics using a mathematical model considering behavior changes" 한국역학회 42 : 1-6, 2020

22 Korea Disease Control and Prevention Agency, "Policy briefing: administering treatment for COVID-19expands to patients with underlying diseases age over 40s"

23 Mohapatra RK, "Omicron(B. 1. 1. 529)variant of SARS-CoV-2 : concerns, challenges, and recent updates" 94 (94): 2336-2342, 2022

24 Rahimi F, "Omicron : a highly transmissible SARS-CoV-2 variant" 27 : 101549-, 2022

25 Thakur V, "Omicron (B. 1.1. 529): a new SARS-CoV-2 variant of concern mounting worldwide fear" 94 (94): 1821-1824, 2022

26 Sonabend R, "Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England : a mathematical modelling study" 398 (398): 1825-1835, 2021

27 Khoury DS, "Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection" 27 (27): 1205-1211, 2021

28 Sarkar K, "Modeling and forecasting the COVID-19 pandemic in India" 139 : 110049-, 2020

29 Bubar KM, "Model-informed COVID-19vaccine prioritization strategies by age and serostatus" 371 (371): 916-921, 2021

30 Jo Youngji ; Kim Sun Bean ; Radnaabaatar Munkhzul ; Huh Kyungmin ; Yoo Jin-Hong ; Peck Kyong Ran ; Park Hojun ; 정재훈, "Model-based cost-effectiveness analysis of oral antivirals against SARS-CoV-2 in Korea" 한국역학회 44 : 1-10, 2022

31 Tuite AR, "Mathematical modelling of COVID-19 transmission and mitigation strategies in the population of Ontario, Canada" 192 (192): E497-E505, 2020

32 Choe Pyoeng Gyun ; Kim Yuri ; Chang Euijin ; Kang Chang Kyung ; Kim Nam Joong ; Cho Nam-Hyuk ; Park Wan Beom ; Oh Myoung-don, "Kinetics of Neutralizing Antibody Responses Against SARS-CoV-2 Delta Variant in Patients Infected at the Beginning of the Pandemic" 대한의학회 37 (37): 1-5, 2022

33 Kretzschmar ME, "Impact of delays on effectiveness of contact tracing strategies for COVID-19 : a modelling study" 5 (5): e452-e459, 2020

34 Murayama H, "Estimating COVID-19 cases infected with the variant alpha(VOC 202012/01) : an analysis of screening data in Tokyo, January-March 2021" 18 (18): 13-, 2021

35 Kucharski AJ, "Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings : a mathematical modelling study" 20 (20): 1151-1160, 2020

36 Min Kyung-Duk ; Tak Sangwoo, "Dynamics of the COVID-19 epidemic in the post-vaccination period in Korea: a rapid assessment" 한국역학회 43 : 1-7, 2021

37 Ministry of Health and Welfare (KR), "Current status of welfare facilities for the elderly"

38 Korea Disease Control and Prevention Agency, "Current COVID-19 status in local"

39 Maslo C, "Characteristics and outcomes of hospitalized patients in South Africa during the COVID-19 Omicron wave compared with previous waves" 327 (327): 583-584, 2022

40 Ko Y, "COVID-19 vaccine priority strategy using a heterogenous transmission model based on maximum likelihood estimation in the Republic of Korea" 18 (18): 6469-, 2021

41 Rosenberg ES, "COVID-19 vaccine effectiveness in New York state" 386 (386): 116-127, 2022

42 Andrews N, "COVID-19 vaccine effectiveness against the Omicron (B. 1.1. 529) variant" 386 (386): 1532-1546, 2022

43 Mahase E, "COVID-19 : Pfizer’s paxlovid is 89% effective in patients at risk of serious illness, company reports" 375 : n2713-, 2021

44 Jihye Um ; Youn Young Choi ; Gayeon Kim ; Min-Kyung Kim ; Kyung-Shin Lee ; Ho Kyung Sung ; Byung Chul Kim ; Yoo-kyoung Lee ; Hee-Chang Jang ; Ji Hwan Bang ; Ki-hyun Chung ; Myoung-don Oh ; Jun-Sun Park ; Jaehyun Jeon, "Booster BNT162b2 COVID-19 Vaccination Increases Neutralizing Antibody Titers Against the SARS-CoV-2 Omicron Variant in Both Young and Elderly Adults" 대한의학회 37 (37): 1-6, 2022

45 Dong Hoon Shin ; Hong Sang Oh ; Haebong Jang ; Sangho Lee ; Byung Seop Choi ; Donghoon Kim, "Analyses of Confirmed COVID-19 Cases Among Korean Military Personnel After Mass Vaccination" 대한의학회 37 (37): 1-13, 2022